Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Opn3 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Opn3 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of OPN3 mRNA | CTD | PMID:22206623 | Opn3 | Rat | 17beta-estradiol | decreases expression | ISO | Opn3 (Mus musculus) | 6480464 | Estradiol results in decreased expression of OPN3 mRNA | CTD | PMID:19484750 | Opn3 | Rat | 17beta-estradiol | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Estradiol results in increased expression of OPN3 mRNA | CTD | PMID:31614463 | Opn3 | Rat | 17beta-estradiol | multiple interactions | ISO | OPN3 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of OPN3 mRNA | CTD | PMID:30165855 | Opn3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of OPN3 mRNA | CTD | PMID:21215274 | Opn3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of OPN3 mRNA | CTD | PMID:20106945|PMID:21632981 | Opn3 | Rat | 2-methylcholine | affects expression | ISO | OPN3 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of OPN3 mRNA | CTD | PMID:21179406 | Opn3 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Opn3 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of OPN3 mRNA | CTD | PMID:28973697 | Opn3 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of OPN3 mRNA | CTD | PMID:31881176 | Opn3 | Rat | acrylamide | affects expression | EXP | | 6480464 | Acrylamide affects the expression of OPN3 mRNA | CTD | PMID:28959563 | Opn3 | Rat | aflatoxin B1 | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of OPN3 mRNA | CTD | PMID:27153756 | Opn3 | Rat | arsenous acid | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of OPN3 mRNA | CTD | PMID:22521957 | Opn3 | Rat | atrazine | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Atrazine results in increased expression of OPN3 mRNA | CTD | PMID:22378314 | Opn3 | Rat | benzo[a]pyrene | increases expression | ISO | Opn3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of OPN3 mRNA | CTD | PMID:19770486 | Opn3 | Rat | benzo[a]pyrene | affects methylation | ISO | OPN3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of OPN3 promoter | CTD | PMID:27901495 | Opn3 | Rat | benzo[a]pyrene | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of OPN3 mRNA | CTD | PMID:20106945|PMID:21632981 | Opn3 | Rat | beta-lapachone | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of OPN3 mRNA | CTD | PMID:38218311 | Opn3 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Opn3 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of OPN3 mRNA | CTD | PMID:34319233 | Opn3 | Rat | bisphenol A | decreases expression | ISO | Opn3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of OPN3 mRNA | CTD | PMID:26063408 | Opn3 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of OPN3 mRNA | CTD | PMID:30816183|PMID:32528016 | Opn3 | Rat | bisphenol A | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of OPN3 mRNA | CTD | PMID:29275510 | Opn3 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of OPN3 gene | CTD | PMID:28505145 | Opn3 | Rat | bisphenol A | decreases methylation | ISO | Opn3 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of OPN3 promoter | CTD | PMID:27312807 | Opn3 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of OPN3 mRNA | CTD | PMID:25181051 | Opn3 | Rat | cadmium dichloride | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of OPN3 mRNA | CTD | PMID:38568856 | Opn3 | Rat | carbon nanotube | increases expression | ISO | Opn3 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of OPN3 mRNA | CTD | PMID:25554681 | Opn3 | Rat | CGP 52608 | multiple interactions | ISO | OPN3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to OPN3 gene] | CTD | PMID:28238834 | Opn3 | Rat | cisplatin | multiple interactions | ISO | OPN3 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of OPN3 mRNA | CTD | PMID:27392435 | Opn3 | Rat | cisplatin | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of OPN3 mRNA | CTD | PMID:27392435 | Opn3 | Rat | cyclophosphamide | affects response to substance | ISO | OPN3 (Homo sapiens) | 6480464 | OPN3 protein affects the susceptibility to Cyclophosphamide | CTD | PMID:16217747 | Opn3 | Rat | cyclosporin A | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of OPN3 mRNA | CTD | PMID:20106945|PMID:25562108|PMID:27989131 | Opn3 | Rat | diarsenic trioxide | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of OPN3 mRNA | CTD | PMID:22521957 | Opn3 | Rat | dicrotophos | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of OPN3 mRNA | CTD | PMID:28302478 | Opn3 | Rat | dorsomorphin | multiple interactions | ISO | OPN3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Opn3 | Rat | doxorubicin | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of OPN3 mRNA | CTD | PMID:29803840 | Opn3 | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of OPN3 mRNA | CTD | PMID:29391264 | Opn3 | Rat | entinostat | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | entinostat results in decreased expression of OPN3 mRNA | CTD | PMID:26272509 | Opn3 | Rat | entinostat | multiple interactions | ISO | OPN3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Opn3 | Rat | ethyl methanesulfonate | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of OPN3 mRNA | CTD | PMID:23649840 | Opn3 | Rat | folic acid | decreases expression | ISO | Opn3 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of OPN3 mRNA | CTD | PMID:25629700 | Opn3 | Rat | folpet | increases expression | ISO | Opn3 (Mus musculus) | 6480464 | folpet results in increased expression of OPN3 mRNA | CTD | PMID:31558096 | Opn3 | Rat | formaldehyde | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of OPN3 mRNA | CTD | PMID:23649840 | Opn3 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of OPN3 mRNA | CTD | PMID:25539665 | Opn3 | Rat | iron atom | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Iron deficiency results in decreased expression of OPN3 mRNA | CTD | PMID:20368581 | Opn3 | Rat | iron(0) | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Iron deficiency results in decreased expression of OPN3 mRNA | CTD | PMID:20368581 | Opn3 | Rat | lead diacetate | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | lead acetate results in decreased expression of OPN3 mRNA | CTD | PMID:38568856 | Opn3 | Rat | methylmercury chloride | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of OPN3 mRNA | CTD | PMID:28001369 | Opn3 | Rat | niclosamide | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of OPN3 mRNA | CTD | PMID:36318118 | Opn3 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of OPN3 mRNA | CTD | PMID:25729387 | Opn3 | Rat | paracetamol | affects expression | ISO | Opn3 (Mus musculus) | 6480464 | Acetaminophen affects the expression of OPN3 mRNA | CTD | PMID:17562736 | Opn3 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of OPN3 mRNA | CTD | PMID:33387578 | Opn3 | Rat | pentanal | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | pentanal results in decreased expression of OPN3 mRNA | CTD | PMID:26079696 | Opn3 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Opn3 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of OPN3 mRNA | CTD | PMID:37995155 | Opn3 | Rat | progesterone | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Progesterone results in increased expression of OPN3 mRNA | CTD | PMID:18037150 | Opn3 | Rat | SB 431542 | multiple interactions | ISO | OPN3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Opn3 | Rat | silicon dioxide | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of OPN3 mRNA | CTD | PMID:25895662 | Opn3 | Rat | sodium arsenite | increases methylation | ISO | Opn3 (Mus musculus) | 6480464 | sodium arsenite results in increased methylation of OPN3 gene | CTD | PMID:32068019 | Opn3 | Rat | sodium arsenite | decreases expression | ISO | Opn3 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of OPN3 mRNA | CTD | PMID:37682722 | Opn3 | Rat | sodium arsenite | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of OPN3 mRNA | CTD | PMID:38568856|PMID:39719251 | Opn3 | Rat | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of OPN3 mRNA | CTD | PMID:19072884 | Opn3 | Rat | sodium arsenite | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of OPN3 mRNA | CTD | PMID:25879800 | Opn3 | Rat | sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of OPN3 mRNA | CTD | PMID:22110744 | Opn3 | Rat | sulforaphane | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | sulforaphane results in increased expression of OPN3 mRNA | CTD | PMID:31838189 | Opn3 | Rat | sunitinib | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of OPN3 mRNA | CTD | PMID:31533062 | Opn3 | Rat | tert-butyl hydroperoxide | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of OPN3 mRNA | CTD | PMID:15336504 | Opn3 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of OPN3 mRNA | CTD | PMID:23411599|PMID:34492290 | Opn3 | Rat | thiram | decreases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Thiram results in decreased expression of OPN3 mRNA | CTD | PMID:38568856 | Opn3 | Rat | titanium dioxide | decreases methylation | ISO | Opn3 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of OPN3 promoter alternative form | CTD | PMID:35295148 | Opn3 | Rat | titanium dioxide | increases methylation | ISO | Opn3 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of OPN3 promoter alternative form | CTD | PMID:35295148 | Opn3 | Rat | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of OPN3 mRNA | CTD | PMID:25729387 | Opn3 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of OPN3 mRNA | CTD | PMID:25729387 | Opn3 | Rat | trichostatin A | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of OPN3 mRNA | CTD | PMID:24935251|PMID:26272509 | Opn3 | Rat | trichostatin A | multiple interactions | ISO | OPN3 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Opn3 | Rat | trimellitic anhydride | increases expression | ISO | Opn3 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of OPN3 mRNA | CTD | PMID:19042947 | Opn3 | Rat | triphenyl phosphate | affects expression | ISO | OPN3 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of OPN3 mRNA | CTD | PMID:37042841 | Opn3 | Rat | triptonide | increases expression | ISO | Opn3 (Mus musculus) | 6480464 | triptonide results in increased expression of OPN3 mRNA | CTD | PMID:33045310 | Opn3 | Rat | valproic acid | increases expression | ISO | OPN3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of OPN3 mRNA | CTD | PMID:24383497 | Opn3 | Rat | valproic acid | decreases methylation | ISO | OPN3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of OPN3 gene | CTD | PMID:29154799 | Opn3 | Rat | valproic acid | affects expression | ISO | OPN3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of OPN3 mRNA | CTD | PMID:25979313 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















